Sponsor:
UCLA
Code:
NCT06189781
Conditions
Cerebral Palsy
Hip Dysplasia
Pain, Postoperative
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Not accepted
Interventions
Ropivacaine injection
Bupivacaine, lidocaine, ropivacaine
Brief summary:
Conditions
Cerebral Palsy
Hip Dysplasia
Pain, Postoperative
Study ID
NCT06189781
Start date
Dec 1, 2023
Status verified date
Jun, 2024
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Dec 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Not accepted
Enrollment
90 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Pain Injection
active comparator: Epidural
Interventions
Ropivacaine injection
Bupivacaine, lidocaine, ropivacaine
Primary outcome measure
Central contacts
Locations
Orthopaedic Institute for Children
Recruiting
Los Angeles, California, United States, 90007
Contacts
Nicole J Hung, MD
310-592-5180Principal Investigator:
Rachel M Thompson, MD
Ronald Reagan UCLA Medical Center
Recruiting
Los Angeles, California, United States, 90095
Contacts
Principal Investigator:
Rachel M Thompson, MD
UCLA Medical Center, Santa Monica
Recruiting
Santa Monica, California, United States, 90404
Contacts
Nicole J Hung, MD
310-592-5180Principal Investigator:
Rachel M Thompson, MD
Sponsor
University of California, Los Angeles
Last update posted
Jun 11, 2024
Last verified
Jun, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of California, Los Angeles on 2024-06-11.